Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank hikes JD Sports price target, shares spark

(Sharecast News) - JD Sports surged on Tuesday after Deutsche Bank upped its price target on the stock to 100p from 85p. "We have thought long and hard about the risk/reward on JD Sports and what would move us from our long held bearish view," the bank said.

"Atop the earnings decline, negative sentiment has driven a material de-rating in the shares, and kept them there. An end to downgrade cycle, line of sight to a Nike comeback and rebuild of confidence in management are all prerequisites, in our view, to supporting an ability to re-rate."

DB said that while progress is beginning to be made, this doesn't necessarily translate into earnings upside.

The bank said it sees two elements warranting more in-depth consideration.

"Firstly, what a Nike comeback looks like in reality for JD Sports as Nike moves to increasingly segment and differentiate wholesale channels whilst bringing new partners on board.

"Secondly, where the balance of risks sits on exposure to US consumer price elasticity; our concern is that it is weighted towards the retailer."

Deutsche kept its 'hold' rating on the shares, which were up 5.7% at 92.82p at 1010 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.